Henry Schein 2009 Annual Report Download - page 125

Download and view the complete annual report

Please find page 125 of the 2009 Henry Schein annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 127

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127

113
Exhibits
10.18 Amended and Restated Change in Control Agreements dated December 12, 2008 between us and
Gerald Benjamin, James Breslawski, Leonard David, Stanley Komaroff, Mark Mlotek, Steven
Paladino, Michael Racioppi and Michael Zack, respectively. (Incorporated by reference to
Exhibit 10.15 to our Annual Report on Form 10-K for the fiscal year ended December 27,
2008.)**
10.19 Form of Note Purchase Agreements between us and the Purchasers listed on Schedule A thereto
relating to an aggregate of $100,000,000 in principal amount of our 6.66% senior notes due July
15, 2010. (Incorporated by reference to Exhibit 10.111 to our Quarterly Report on Form 10-Q for
the quarter ended September 26, 1998.)
10.20 Credit Agreement among us, the several lenders parties thereto, JPMorgan Chase Bank, N.A., as
administrative agent and HSBC Bank USA, N.A., The Bank of New York Mellon, and UniCredit
Markets and Investment Banking, acting through Bayerische Hypo- und Vereinsbank AG, New
York Branch, as co-syndication agents, dated as of September 5, 2008. (Incorporated by reference
to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended September 27,
2008.)
10.21 Amendment dated November 29, 2009 to the Credit Agreement among us, the several lenders
parties thereto, JPMorgan Chase Bank, N.A., as administrative agent and HSBC Bank USA,
N.A., The Bank of New York Mellon, and UniCredit Markets and Investment Banking, acting
through Bayerische Hypo- und Vereinsbank AG, New York Branch, as co-syndication agents,
dated as of September 5, 2008.+
10.22 Distribution Agreement entered into as of December 2, 2004, by and between us and ID
Biomedical Corporation. (Incorporated by reference to Exhibit 10.31 to our Annual Report on
form 10-K for the year ended December 25, 2004.)*
10.23 Amendment dated October 2, 2006 to Distribution Agreement, dated as of December 2, 2004, by
and between us and ID Biomedical Corporation. (Incorporated by reference to Exhibit 10.20 to
our Annual Report on Form 10-K for the fiscal year ended December 27, 2008.)*
10.24 Second Amendment dated October 5, 2006 to Distribution Agreement, dated as of December 2,
2004, by and between us and ID Biomedical Corporation. (Incorporated by reference to Exhibit
10.21 to our Annual Report on Form 10-K for the fiscal year ended December 27, 2008.)
10.25 Amendment dated December 20, 2007 to Distribution Agreement, dated as of December 2, 2004,
by and between us and ID Biomedical Corporation. (Incorporated by reference to Exhibit 10.22 to
our Annual Report on Form 10-K for the fiscal year ended December 27, 2008.)
10.26 Amendment dated October 15, 2008 to Distribution Agreement, dated as of December 2, 2004,
by and between us and ID Biomedical Corporation. (Incorporated by reference to Exhibit 10.23
to our Annual Report on Form 10-K for the fiscal year ended December 27, 2008.)*
10.27 Amendment dated February 9, 2010 to Distribution Agreement, dated as of December 2, 2004, by
and between us and ID Biomedical Corporation.*+